NRG-BN011: A Phase III Trial of Lomustine-Temozolomide Combination Therapy Versus Standard Temozolomide in Patients with Methylated MGMT Promoter Glioblastoma
- Title
- A Phase III Trial of Lomustine-Temozolomide Combination Therapy Versus Standard Temozolomide in Patients with Methylated MGMT Promoter Glioblastoma
- Principal Investigator
- Aulakh, Sonikpreet
- Phase
- III
- Age Group
- Adult
- Applicable Disease Sites
- Brain Cancer
- Participating Institutions
- Mary Babb Randolph Cancer Center
- Contacts
- Nina Moore, RN
- Research Specialist
- Phone: +1 304-293-2991
- Email: nina.moore@hsc.wvu.edu